Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders

Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and α-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD). We screened 83 patients with CMD and other neuromuscular disorders and six controls for mutatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peat, Rachel A., Gécz, Jozef, Fallon, Justin R., Tarpey, Patrick S., Smith, Raffaella, Futreal, Andrew, Stratton, Michael R., Lamandé, Shireen R., Yang, Nan, North, Kathryn N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2873833/
https://ncbi.nlm.nih.gov/pubmed/18602826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nmd.2008.05.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados